Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Explore the credit cards with the best rewards programs to maximize your benefits and savings. Find your perfect match.
26,855 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A clear spark lit up Rivian stock as the R2 SUV launch was confirmed. This piece breaks down what it means for the st...
As Taysha prepares to share Q4 2025 results, investors search for clarity on cash runway, pipeline progress, and futu...
One Florida resident lived in a hotel for 2.5 years, paying about $1,228 a month while avoiding typical renter hurdle...
Warren Buffett's successor, Greg Abel, is drawing new attention as recent 13F filings hint at a shift in Berkshire's ...
Gary Vaynerchuk is delivering a blunt rallying cry on AI: dedicate at least an hour daily to hands-on AI work. The me...
Investors pulled record cash from Bitcoin ETFs in June while Hyperliquid’s new funds drew persistent inflows, signali...
Hyperliquid’s HYPE token surged past $60, signaling a shift toward an on-chain Wall Street platform as institutions e...
A Deloitte-recognized fastest-growing software firm opens the last phase of a pre-IPO funding round, offering micro-s...
Bitdeer, a leading Bitcoin miner, has sold its entire BTC stash, signaling a strategic pivot that could influence nea...
A notable fund trimmed its stake in Core Scientific while the stock jumped dramatically. This article breaks down wha...
As BTC prices wobble, bitcoin miners using bear keys pivot to AI compute. A SpaceX Colossus 1 deal with Anthropic sig...